Wolverine Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Buy
207,915
+191,955
+1,203% +$2.3M 0.02% 503
2026
Q1
$95.6K Sell
15,960
-9,600
-38% -$72.2K ﹤0.01% 1189
2025
Q4
$183K Buy
25,560
+9,362
+58% +$74K ﹤0.01% 1119
2025
Q3
$173K Sell
16,198
-6,295
-28% -$61.8K ﹤0.01% 1039
2025
Q2
$218K Buy
22,493
+1,493
+7% +$15.4K ﹤0.01% 1016
2025
Q1
$313K Buy
21,000
+335
+2% +$5.15K ﹤0.01% 941
2024
Q4
$308K Buy
20,665
+4,608
+29% +$75.1K ﹤0.01% 948
2024
Q3
$307K Hold
16,057
﹤0.01% 962
2024
Q2
$332K Hold
16,057
﹤0.01% 911
2024
Q1
$302K Sell
16,057
-7,300
-31% -$125K ﹤0.01% 904
2023
Q4
$337K Buy
+23,357
New +$318K ﹤0.01% 958

Other funds holding OGN

Wolverine Asset Management's OGN Position: Q2 2026 in Review

Wolverine Asset Management increased its Organon & Co (OGN) stake by 1,203% in Q2 2026, buying an estimated $2.3M and bringing the position to 207,915 shares worth $2.82M. The position accounts for 0.02% of the portfolio, ranked #503.

Wolverine Asset Management first reported a position in OGN in Q4 2023 and has held it in 11 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Wolverine Asset Management held 207,915 shares of Organon & Co worth $2.82M as of Q2 2026.
  • Wolverine Asset Management bought 191,955 Organon & Co shares in Q2 2026, an estimated $2.3M.
  • Organon & Co made up 0.02% of Wolverine Asset Management's portfolio in Q2 2026, its #503 holding.
  • Wolverine Asset Management first reported a position in Organon & Co in Q4 2023 and has held it in 11 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.